NIH scientists discovered key pathway in lysosomes that coronaviruses use to exit cells
On Oct. 28, 2020, researchers at the NIH announced that they had discovered a biological pathway that the…
Postpartum depression may persist three years after giving birth
On Oct. 27, 2020, a National Institutes of Health (NIH) study of 5,000 women found that approximately 1…
Scientists used clues in the human genome to discover new inflammatory syndrome
On Oct. 27, 2020, Researchers from the National Institutes of Health (NIH) announced they had discovered a new…
Plant compound reduced cognitive deficits in mouse model of Down syndrome
On Oct. 23, 2020, NIH researchers reported that the plant compound apigenin improved the cognitive and memory deficits…
Final report confirmed remdesivir benefits for COVID-19
On Oct. 20, 2020, the NIH announced that the researchers had completed the Adaptive COVID-19 Treatment Trial (ACTT-1),…
PerkinElmer immunoassay identiied therapeutic compounds capable of disrupting the SARS-CoV-2 spike protein/ACE2 interaction
On Oct. 20, 2020, PerkinElmer announced that a research team at the National Center for Advancing Translational Sciences…
Study discovered gene that helps us know when itï¾’s time to urinate
On Oct. 19, 2020, researchers annoounced they had discovered that a gene, called PIEZO2, may be responsible for…
NIH began large clinical trial to test immune modulators for treatment of COVID-19
On Oct. 16, 2020, the NIH launched an adaptive Phase 3 clinical trial to evaluate the safety and…
NIH launched its ACTIV-5 ‘Big Effect Trial’ evaluating Humanigen’s Lenzilumabas potential COVID-19 therapy
On Oct. 13, 2020, Humanigen announced that the National Institute of Allergy and Infectious Diseases (NIAID), had launched…
NIH study to identify promising COVID-19 treatments for larger clinical trials
On Oct. 13, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), launched a study designed to…
Biotechnology | COVID-19 | Disease | Life Science News | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $1.4 million to study COVID-19 in Latino Americans
On Oct. 8, 2020, the La Jolla Institute for Immunology (LJI) announced it had been granted $1.4 million…
Yale Cancer Center received NIH grant to fund COVID-19 research in patients with hematologic cancers
On Oct. 8, 2020, the National Institutes of Health (NIH) awarded a Research Project Cooperative Agreement grant to…
NIH supported 85 new grants featuring high-risk, high-reward research
On Oct. 6, 2020, the NIH announced it had awarded 85 grants through its High-Risk, High-Reward Research (HRHR)…
NIH RADx initiative advanced six new COVID-19 testing technologies
On Oct. 6, 2020, the National Institutes of Health (NIH), working in collaboration with the Biomedical Advanced Research…
SARS-CoV-2 may use key carbohydrate to infect cells
On Oct. 6, 2020, NIH researchers announced they had found that a carbohydrate called heparan sulfate, which is…
NIH assessed and expanded COVID-19 testing for underserved communities
On Sept. 30, 2020, the NIH announced that it had awarded nearly $234 million to improve COVID-19 testing…
NIH funded first nationwide network to study rare forms of diabetes
On Sept. 30, 2020, the NIH announced funding of a nationwide study to discover the cause of several…
Computer-designed proteins may protect against coronavirus
On Sept. 29, 2020, the NIH announed that researchers had designed ﾓminiproteinsï¾” that bound tightly to the SARS-CoV-2…
COVID-19 vaccine generated immune response in older adults
On Sept. 29, 2020, a phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection was…
NIH-funded study shed light on abnormal neural function in rare genetic disorder
On Sept. 28, 2020, a genetic study identified neuronal abnormalities in the electrical activity of cortical cells derived…
NIH expanded clinical trials to test convalescent plasma against COVID-19
On Sept. 22, 2020, the NIH annunced that two randomized, placebo-controlled clinical trials expanded enrollment to further evaluate…
NIH funded community engagement research efforts in areas hardest hit by COVID-19
On Sept. 16, 2020, the NIH announced a $12 million award for outreach and engagement efforts in ethnic…
NIH awarded contracts worth $228 million to develop innovative digital health technologies for COVID-19
On Sept. 15, 2020, the NIH awarded seven contracts worth a total of $22.8 million to companies and…
Baricitinib in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 in ACTT-2 Trial
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
NIH ACTIV initiative launched adaptive clinical trials of blood-clotting treatments for COVID-19
On Sept. 10, 2020, the NIH launched two of three adaptive Phase 3 clinical trials evaluating the safety…
NIH augmented large scale study of Alzheimer’s disease biomarkers
On Sept. 10, 2020, the NIH announced that it had added funding for more biomarker measures, including positron…
Study showed U.S. decline in awareness, treatment and control of high blood pressure
On Sept. 9, 2020, the National Institutes of Health (NIH) announced that after nearly 15 years on an…
Lenzilumab COVID-19 case-control study published in Mayo Clinic Proceedings Journal
On Sept. 3, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…
NIH to boost national COVID-19 testing capacity
On Sept. 2, 2020, the NIH announced $129.3 million in scale-up and manufacturing support for a new set…
Aegis Sciences awarded $66 million NIH grant to rapidly expand COVID-19 test capacity
On Sept. 2, 2020, Aegis Sciences annunced that it had been selected to participate in the National Institutes…